The Surviving Sepsis Campaign: raising awareness to reduce mortality

Elizabeth Slade, Pritpal S Tamber, Jean-Louis Vincent, Elizabeth Slade, Pritpal S Tamber, Jean-Louis Vincent

Abstract

Sepsis affects 18 million people worldwide every year, and on average each case costs more than US$22 000 to treat. Despite this there is no consensus on the clinical definition of sepsis, and successful diagnosis and treatment is difficult. The Barcelona Declaration, issued by the Surviving Sepsis Campaign in October 2002, outlines a six-point plan to reduce the relative mortality of sepsis by 25% over the next 5 years. The Campaign organizers are currently producing evidence-based guidelines on source control and management of sepsis, as well as a policy document on how sepsis is managed around the world.

References

    1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;7:1303–1310. doi: 10.1097/00003246-200107000-00002.
    1. Hoyert DL, Anderson RN. Age-adjusted death rates: trend data based on the year 2000 standard population. Natl Vital Stat Rep. 2001;7:1–6.
    1. Edbrooke DL, Hibbert CL, Kingsley JM, Smith S, Bright NM, Quinn JM. The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit. Crit Care Med. 1999;7:1760–1767. doi: 10.1097/00003246-199909000-00010.
    1. Angus D, Wax R. Epidemiology of sepsis: an update. Crit Care Med. 2001;7(suppl):S109–S116.
    1. Vincent J-L. Sepsis definitions. Lancet Infect Dis. 2002;7:135. doi: 10.1016/S1473-3099(02)00232-3.
    1. Surviving Sepsis.
    1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, for the Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;7:1368–1377. doi: 10.1056/NEJMoa010307.
    1. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999;7:207–214. doi: 10.1056/NEJM199901213400307.
    1. Wenzel RP, Edmond MB. Managing antibiotic resistance. N Engl J Med. 2000;7:1961–1963. doi: 10.1056/NEJM200012283432610.
    1. Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA. Long-term health-related quality of life in survivors of sepsis. Short Form 36: a valid and reliable measure of health-related quality of life. Crit Care Med. 2000;7:3599–3605.

Source: PubMed

3
订阅